Pricing Log in Create free account

Abeona Therapeutics Inc. (ABEO) vs Palisade Bio, Inc. (PALI)

Abeona Therapeutics Inc. and Palisade Bio, Inc. are both Biotechnology companies. Abeona Therapeutics Inc. and Palisade Bio, Inc. are of similar size ($268.4M and $265.9M). Abeona Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; Palisade Bio, Inc. trades at 2.2×. Palisade Bio, Inc. grew revenue faster over the last twelve months: 5,492.6% against 427.5%. Abeona Therapeutics Inc. has the higher net margin (−242.6% vs −4,230.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Abeona Therapeutics Inc. leads on 10 and Palisade Bio, Inc. on 7.

Valuation

Metric ABEO PALI Biotechnology median
P/E n/m 2.18 8.50
P/S 9.68 394.77 9.71
P/B 1.96 2.45 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 4.60 229.61 9.21
Earnings yield (26.59%) 45.93% (33.15%)
Free cash flow yield (32.48%) (6.11%) (25.50%)

Profitability

Metric ABEO PALI Biotechnology median
Gross margin 66.03% 95.63% 65.16%
Operating margin (322.59%) (4,681.99%) 0.00%
Net margin (242.62%) (4,230.60%) 0.00%
Free cash flow margin (314.53%) (2,409.27%) 0.00%
Return on equity (43.13%) (51.37%) (56.36%)
Return on assets (29.54%) (47.68%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ABEO PALI Biotechnology median
Revenue growth (TTM) 427.47% 5,492.59% 6.02%
EPS growth (last fiscal year) 165.16% 97.06% 30.26%
Revenue growth, 5-year CAGR 14.19% 72.86% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABEO PALI Biotechnology median
Debt to equity 0.12 0.00 0.00
Current ratio 6.63 24.26 4.72
Net debt to EBITDA 2.00 7.37 0.96

Dividend

Metric ABEO PALI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ABEO PALI Biotechnology median
Market cap 265.90m 268.38m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack